Searched for
HCQS TABLETS
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring ...
- Pharma sector: Reasons to look at it beyond the tariff exemption. 7 pharma stocks with an upside potential of up to 43%Along with semiconductors, electronics and IT, pharma is another sector exempt from the Trump tariffs. Still, as the broader indices declin...
- They fall, you catch. One might be a winner in the long term: 8 pharma stocks with upside potential of over 35%Given that the headlines are dominated by what is happening at the border, the street may be forgiven for not noting developments that matt...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of more than 33% in 1 yearBack in September 2024, who would have thought that bulls would vanish from the street in just six months, and bears would rule? But market...
- Necessary pill for portfolio during volatility and Trump tariff wars: 8 pharma stocks with an upside potential of up to 48%Let’s accept the fact that we are likely to be dealing with volatility for the next four years. Both in the real world and in the global an...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 26%When bears go on a rampage, they don’t discriminate. So, on Monday, no matter what sector, what market cap, everything was in the red. But ...
- A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 yearWhen Donald Trump is back in the saddle, one thing is certain: Tariff wars. Yes, China will be the biggest target. But for all those who th...
- Alpha generators in the long term: 9 mid and small cap stocks from pharma and healthcare sector with an upside potential of up to 29%While some make it to the headlines, some don't. Two sectors, healthcare and pharma have been witnessing more mergers and acquisitions than...
- These healthcare and pharma stocks may deliver more than 20% in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
- For all market conditions: 5 largecap stocks from different sectors with upside potential of up to 33%The US interest rates and yields are one of the most important drivers of liquidity in global markets. That is the reason at the first hint...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...
- Will Gilead’s Covid-19 drug lift sustain for Jubilant Life, Cipla?Use of remdesivir is said to reduce hospital stay by 31 per cent to 11 days from 15 days.
- Indian Foreign Minister speaks to his counterparts from US, Russia, Saudi, Oman and Brazil on pandemicIn a series of tweets Foreign Minister S Jaishankar gave an overview of his conversations.
- Residents in Mumbai hotspots to be given HCQ as a preventiveResidents of civic wards in Mumbai with a high number of Covid-19 cases will be given hydroxychloroquine tablets as a preventive treatment,...
- Maharashtra government may hand out HCQ tablets in slums to curb Covid spreadA state government official said that the government is considering handing out the HCQS tablets as a preventive measure, and that suspecte...
- Hydroxychloroquine becomes a Schedule H1 drug as hoarding leads to shortageThe hoarding and shortage took place after the Indian Council of Medical Research (ICMR) recommended the drug for front line workers and hi...
- Covid-19: Forget healing touch, pharma gets it roughThe national lockdown has hit pharmaceutical companies hard as restrictions on movement of goods and people imposed by the police led to a ...
- Pharma companies in panic mode as lockdown hits supply chainThe ban on public transportation is making it difficult for labourers to reach manufacturing plants. All the ancillary goods required for m...
Load More
